GENE ONLINE|News &
Opinion
Blog

Multiple Myeloma
Trials & Approvals Multiple Myeloma
GSK’s anti-BCMA Therapy Notches FDA Approval for Refractory Multiple Myeloma
2020-08-09
Trials & Approvals
BMS, bluebird bio’s Investigational BCMA CAR-T Therapy Faces Regulatory Setback
2020-05-18
Trials & Approvals Multiple Myeloma
GSK Wins EMA Approval to Market Multiple Myeloma Treatment
2020-02-16
Trials & Approvals Multiple Myeloma
Empliciti®(elotuzumab) combination – New IO approval for relapsed Multiple Myeloma
2018-11-09
Policy
Taiwan Approves Six Cell Therapies Under Revised Guidelines
2018-09-13
1 2
LATEST
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15
Tribal Leaders Warn Senators: Federal Health Funding Cuts Threaten Native American Health.
2025-05-14
Health Secretary Kennedy Retracts Parts of Agency Reorganization Plan During Combative Congressional Hearing
2025-05-14
SURMOUNT-5 Trial: Zepbound Shows Greater Weight Loss Than Wegovy
2025-05-14
ASCGT Meeting Navigates Biotech Downturn After Multi-Year Slump
2025-05-14
Seasonal Skin Irritations Rise, Driving Demand for Accessible and Easy-to-Use Treatments
2025-05-14
Tirzepatide Users See 20.2% Average Weight Loss in Obesity Management Trial
2025-05-14
READ MORE
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-26
2025 Antibody Therapeutic & Frontiers in Biomedical Sciences Conference
Taipei, Taiwan
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top